Sammanställning av prover som tillgänliggjorts för forskning

ApplicantNOPHO project reference numberNOPHO project nameYearProvided samples with cellsProvided samples with DNAProvided samples with RNAProvided samples with serum
Randi Hovland Henrik HaslePresentation in Turku supportedKIT och RAS mutations in CBS AML A NOPHO-AMLstudy201118   
Julie Damgaard  20112   
Erik Forrestier Sofie Degerman DNA promoter methylation as a prognostic marker in T-ALL201368   
Louise Rold Helt  20145   
Gudmar Lönnerholm  2015563   
Kjeld Schmiegelow Stine Nygaard NielsenStudy 82 Approved by the boardStudy 82 Aquired thiopurine resistance in relapsing ALL20153   
Kjeld Schmiegelow Stine Nygaard NielsenStudy 82 Approved by the boardStudy 82 Aquired thiopurine resistance in relapsing ALL20152   
Kjeld Schmiegelow Hanne MarquartStudy 84 CRLF2/IL7Study 84 CRLF2/IL7: Investigation of activity and expression of the IL7 related signaling pathway including STAT-5 phosphorylation in BCP- and T-ALL in patients from the NOPHO-ALL2008 protocol2015263   
Anna AnderssonStudy 118Study 118 Genome-wide analysis of MLL-rearranged leukemia and fuctional studies to identify201615   
Sanne NoortNOPHO-2015-15/R1-(20)Part of NOPHO-AML 2004, sent to Erasmus, Holland201621   
Kim Ramme  20163   
Britt Gustavsson Kristin Mattsson Molecular biological studies on etiologic factors in leukemia in children via analysis of PKU blood samples2016 3  
Linda Holmfeldt Multi-level analysis of acute myeloid leukemia2016-201769   
Kristian Juul-Dam Early relapse detection study20172   
Morten Herlin AML-NOS, Genomic profiling of pediatric AML201841   
Erik Delsing Malmberg Early detection of relapse AML20182   
Ann-sofie SkouNOPHO 2017-11 (72)Early relaps NOPHO AML / Sensitive methods for AML20194   
Olli LohiNOPHO 2018-10RNOPHO project n:o 96 Genomics-based tools for personalized treatment to reduce chemotherapy burden in pediatric leukemia (GEPARD)2019 2828 
Ninna Brix Uggerby, Arhus, DkNOPHO-2019-15 – (124)The use of biomarkers S100, M-ficolin, CL-K1 and MASP-3 in separating children with leukemia and joint involvement from children with juvenile idiopathic arthritis2020   151
Sofie DegermanNOPHO Study No 70NOPHO Study No 70 Prognostic and biological relevance of DNA methylation in T-ALL – an extension of NOPHO Study No 702020 134  
Jochen BuchnerApproved by NOPHO Board, ALL WG, Scientific committee och LLCNot a formal NOPHO projekt20204   
Anders Östlund/Lars PalmqvistNOPHO-2018-8/R1Determine incidence, prognosis and mechanisms for acute myeloid leukemia with t(7;12)(q36;p13)2021 1738 
Sofie DegermanNOPHO Study No 70NOPHO Study No 70 Prognostic and biological relevance of DNA methylation in T-ALL – an extension of NOPHO Study No 702021  125 
Vasilios ZachariadisNOPHO-2019-14-122Analys av genetiska förändringar och genuttryck vid akut lymfatisk leukemi hos barn20211   
   Total1086182191151